BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 21, 2012
View Archived Issues
Data reported on effects of HSC gene therapy for metachromatic leukodystrophy
Read More
Sonic hedgehog pathway inhibitors disclosed by U.S. researchers
Read More
Teva Pharmaceutical Industries patents novel compounds for MS
Read More
Novel histone deacetylase inhibitors prepared by Georgia Tech Research Corp.
Read More
Promising results reported for first patients in phase I trial of VRX-007
Read More
In vivo studies show new therapeutic potential for CDDO-Me
Read More
Daclatasvir shows promise in difficult-to-treat populations
Read More
Alisporivir results in hepatitis C virus genotypes 1, 2 and 3 reported
Read More
Novel protease inhibitors for HIV patented
Read More
Monash University presents new antimicrobial peptides
Read More
Merz Pharma designs novel cognition-enhancing drugs
Read More
Novel AMPK activators designed by Roche
Read More
Anti-marinobufagenin antibody studied in salt-sensitive hypertension
Read More
Taisho updates pipeline progress for fiscal 2011
Read More
Shionogi reviews pipeline progress of fourth quarter of fiscal 2011
Read More
Janssen gains Japanese approval for anti-HIV agent
Read More
Agilent set to acquire leading cancer diagnostic company
Read More
ArQule and Daiichi Sankyo complete patient recruitment in phase III tivantinib study
Read More
Ocera obtains CE Mark for Zysa
Read More
Half of target patient population recruited in phase III tasquinimod study
Read More
ASLAN obtains global rights to Almirall's DHOdehase inhibitor
Read More
Pharmaxis submits NDA for Bronchitol
Read More
Helix BioPharma receives clearance for European phase III study in low-grade cervical lesions
Read More
MRC Technology and Queen Mary University of London enter multiple GPCR collaborations
Read More